| 1 min read
Register for free to listen to this article
Listen with Speechify
0:00
1:00
WEST LAFAYETTE, Ind.—Protein-protein interactions are typically mediated by post-translational modifications, but when one protein carries multiple modification sites, it can be difficult to determine which residues play what roles in the interaction. Recently, however, scientists at Purdue University developed a multiplex method to identify and quantitate interactions between proteins and selectively phosphorylated peptides.
 
As described in the Journal of Proteome Research, the researchers focused their attention on Syk, a protein-tyrosine kinase involved in multiple signal transduction pathways. The researchers synthesized four peptides carrying two tyrosine residues (Syk 338-353) without phosphorylation or phosphorylated at either or both tyrosines, and attached the peptides to resin beads.
 
The researchers incubated the beads with equal amounts of cell lysates to affinity purify peptide-binding proteins. After eluting the proteins and digesting them with trypsin, the researchers labeled the peptides associated with each peptide with a different iTRAQ tag. They then combined the labeled peptides for LC-MS/MS analysis.
 
Nonspecifically bound proteins will result in equally large iTRAQ peaks, whereas if a protein binds selectively to one peptide, the peak from that sample will be larger than for the other samples, and the ratio of peak size will be related to the degree of binding specificity. The researchers found 11 proteins with distinct binding preferences and were surprised to find some proteins never suspected to be involved with Syk.

About the Author

Related Topics

Loading Next Article...
Loading Next Article...
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

A blue x-ray style image of a human body is shown with the liver illuminated in orange against a dark blue background.

Harnessing liver-on-a-chip models for drug safety

Discover how researchers leverage microphysiological systems in toxicology studies.  
A person wearing a white lab coat types on a laptop with various overlaid enlarged files shown with plus signs on file folders floating over the laptop screen with a clinical lab shown in the background in grey and white tones.

Enhancing bioanalytical studies with centralized data management

Learn how researchers can improve compliance and efficiency with advanced LIMS solutions.
A 3D-rendered digital illustration of a molecular structure floating among red blood cells in a bloodstream environment.

Explained: How are metabolite biomarkers improving drug discovery and development?

By offering a rich source of insights into disease and drugs, metabolite biomarkers are at the forefront of therapeutic exploration.
Drug Discovery News March 2025 Issue
Latest IssueVolume 21 • Issue 1 • March 2025

March 2025

March 2025 Issue

Explore this issue